Introduction
Class III antiarrhythmic drugs appear to affect the heart by blocking potassium channels (Colatsky and Follmer, 1990) . Four types of potassium channel occur in a variety of tissues: voltage-activated, Ca-dependent, ATP-sensitive and receptormediated (Muniz et al, 1992 , Ferrer et al, 1995 , the last type including muscarinic-linked channels (Kurachi, 1995) . However, there appears to be little information on their occurrence in the testis, except that voltage-activated channels do not appear to be present (Muniz et al, 1992) . During fhe testing of a new Class III anti-arrhythmic drug, Almokalant (H234/09; Astra-Hässle, Mölndal), it was noticed that the testes of male rats became atrophied after prolonged treatment with the drug.
Since potassium transport may be the basis for fluid secretion by the Sertoli cells in the testis (Waites and Gladwell, 1982;  Hinton and Setchell, 1993) , it is possible that the cause of this atrophy was an interference with potassium and fluid secretion by the Sertoli cells. This possibility was tested and evidence for the involvement of potassium transport in fluid secretion in the testis was obtained by studying the effect of short-term administration of this drug or another Class III antiarrhythmic drug (Dofetilide, Pfizer, New Setchell and Main (1975) ; the volume was recorded from the length of the fluid column and the sample diluted with three volumes of saline before centrifu¬ gation at 1000 g for 5 min to remove the spermatozoa. The right testis was exposed and blood was collected from a testicular vein as described by Galil and Setchell (1988 Expt 2, treatment had no effect on body mass (Table 2) .
Histology
All control testes appeared normal (Fig. la) (Fig. lc) (Fig. lb, d The only other treatments to cause such a profound and sudden decrease in fluid secretion are an intratesticular injection of colchicine or treatment of young rats with di-n-pentylphthalate. A dose of 4 µg colchicine produced a 30% decrease within the next 16 h, and 40 µg almost stopped fluid produc¬ tion, measured in the same way as in the present study (Allard et al, 1993) . Exposure of isolated tubules to colchicine or an inhibitor of protein synthesis (Brefeldin A) inhibited fluid secretion in vitro, as measured by the rate of movement of a luminal oil droplet (Richburg et al, 1994) and, in vivo, there was complete inhibition of fluid secretion by the testes beginning 1 h after exposure of immature rats to 2.2 g di-npentylphthalate kg- (Gray and Gangolli, 1986) . Other treat¬ ments had effects only after prolonged treatment. For example, the addition of 2,5-hexanedione to the drinking water of rats for 5 weeks initially had no effect on fluid secretion, although after about 4 weeks, fluid secretion fell by approximately 50%, and remained depressed for several weeks after the end of treatment (Johnson et al, 1991; Richburg et al, 1994 
